| Metric | Value ($ M) | Q1 FY25 |
|---|---|---|
| Revenue | 224.68 | 0.8% |
| Total Income | 224.68 | 0.8% |
| Expenditure | 222.16 | 5.7% |
| PBT | 4.27 | 136.6% |
| Net Profit | 4.27 | 136.6% |
| OPM | 1.12% | 5.09pp |
| NPM | 1.90% | 7.06pp |
| EPS | 0.05 | 131.3% |
Alto Ingredients Reports Q1 2026 Results: Net Income of $4.0 Million
07 May 2026 · 7 May, 1:59 am
Summary
Alto Ingredients, Inc. reported its financial results for the quarter ended March 31, 2026. The company achieved profitability on an adjusted EBITDA and net income basis, driven by strong export sales, higher crush margins, and incremental earnings from Section 45Z tax credits. Net sales were $224.7 million compared to $226.5 million. Net income attributable to common stockholders was $4.0 million, or $0.05 per diluted share, compared to a net loss of $12.0 million, or $0.16 per share in the prior year. Adjusted EBITDA was $4.7 million, compared to negative $4.4 million in the prior year.
Key Highlights
- 1
Alto Ingredients reported a Q1 2026 gross profit of $9.2 million, an increase of $11.0 million year-over-year.
- 2
Net income for Q1 2026 was $4.0 million, or $0.05 per share, improving by $16.0 million compared to the previous year.
- 3
Adjusted EBITDA for Q1 2026 improved by $9.1 million to $4.7 million compared to Q1 2025.
- 4
Net sales were $224.7 million, slightly lower than the $226.5 million reported in the same quarter of the previous year.
- 5
Cash and cash equivalents at March 31, 2026, were $20.3 million, compared to $23.4 million at December 31, 2025.
- 6
Borrowing availability at March 31, 2026, was $94.3 million, including $29.3 million under the operating line of credit.
Management Comments
Bryon McGregor
In a seasonally weak period for Alto and the industry, we delivered profitability on an adjusted EBITDA and net income basis through the contributions of strong export sales, higher crush margins and incremental earnings from Section 45Z tax credits. Even without the contribution of the tax credits we were profitable. Looking ahead, our priorities are straightforward: improve utilization and reliability; execute our 2026 optimization and capital projects on time and on budget; and leverage the flexibility we have with multiple revenue streams to respond to market shifts and perform profitably through commodity cycles. In addition, we are focused on expanding the value we capture from 45Z tax credits and on optimally monetizing the value of our biogenic CO2 production across our facilities to lower our carbon footprint. Through our focus on these priorities, we remain committed to enhancing the value of our assets.
Informational and educational content only. Not investment advice.